- Patent Title: Glucosylceramide synthase inhibitors for the treatment of diseases
-
Application No.: US15556786Application Date: 2016-03-10
-
Publication No.: US10227312B2Publication Date: 2019-03-12
- Inventor: Bing Wang
- Applicant: BIOMARIN PHARMACEUTICAL INC.
- Applicant Address: US CA Novato
- Assignee: BIOMARIN PHARMACEUTICAL INC.
- Current Assignee: BIOMARIN PHARMACEUTICAL INC.
- Current Assignee Address: US CA Novato
- Agency: Jones Day
- International Application: PCT/US2016/021706 WO 20160310
- International Announcement: WO2016/145153 WO 20160915
- Main IPC: C07D265/02
- IPC: C07D265/02 ; C07D217/26 ; C07D311/76 ; C07D311/94 ; C07D409/04 ; C07D413/12 ; C07D495/04 ; C07D498/04

Abstract:
Described herein are compounds of Formula I, methods of making such compounds, pharmaceutical compositions and medicaments containing such compounds, and methods of using such compounds to treat or prevent diseases or conditions associated with the enzyme glucosylceramide synthase (GCS).
Public/Granted literature
- US20180044302A1 GLUCOSYLCERAMIDE SYNTHASE INHIBITORS FOR THE TREATMENT OF DISEASES Public/Granted day:2018-02-15
Information query